Solesis Acquires Polyzen
November 3, 2022
Solesis, an operating company backed by Altaris, has acquired Polyzen, a contract developer and manufacturer of polymer-based films, coatings, components and assemblies for the medical device and biopharmaceutical markets. Polyzen will operate as a subsidiary of Solesis, expanding Solesis' polymer film and coating capabilities to better serve medical device, bioprocessing, drug delivery and cell and gene therapy customers.
- Buyers
- Solesis, Altaris
- Targets
- Polyzen
- Platforms
- Solesis
- Industry
- Medical Devices
- Location
- North Carolina, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Altaris Acquires 51% Stake in Solesis from Michelin
June 1, 2021
Medical Devices
Altaris Capital Partners has completed the acquisition of a 51% stake in Solesis from Michelin, with Michelin retaining a 49% ownership interest and partnering with Altaris to build Solesis as an independent company. Solesis, a U.S.-based biomaterials and medical-device components manufacturer operating through The Secant Group, Charter Medical and SanaVita Medical, employs approximately 360 people across production facilities in Pennsylvania and North Carolina.
-
Biosynth Acquires celares to Expand Bioconjugation and Polymer Drug Delivery Capabilities
July 11, 2023
Biotechnology
Biosynth, a Switzerland-based supplier of critical raw materials and manufacturing services, acquired Berlin-based celares, a developer and manufacturer of bioconjugates, activated PEGs and polymer-based drug delivery excipients. The acquisition strengthens Biosynth's capabilities in conjugate vaccines and bioconjugate drugs and adds GMP bioconjugation and PEGylation manufacturing in Berlin to its service offering.
-
Collagen Matrix Acquires Polyganics
October 5, 2022
Medical Devices
Collagen Matrix, a Linden Capital Partners portfolio company, has acquired Polyganics B.V., a Netherlands-based developer and manufacturer of bioresorbable medical devices. The add-on acquisition expands Collagen Matrix's regenerative medicine and polymer capabilities, entering new clinical verticals such as ENT and general surgery and broadening its neurosurgery and peripheral nerve offerings.
-
Sartorius Stedim Biotech Acquires Polyplus
April 13, 2023
Biotechnology
Sartorius Stedim Biotech agreed to acquire Strasbourg-based Polyplus (Polyplus‑transfection S.A.) for €2.4 billion, pending customary regulatory approvals. The transaction buys the business from private equity backers including ARCHIMED and Warburg Pincus and strengthens Sartorius’s cell & gene therapy reagent and upstream bioprocessing portfolio.
-
Polytek Development Corp. Acquires Specialty Resin & Chemical
September 7, 2021
Manufacturing
Polytek Development Corp., a portfolio company of Arsenal Capital Partners, acquired Specialty Resin & Chemical, a Dowagiac, Michigan–based supplier of mold making, casting, and coating resins. Daniel Wilson, the owner of Specialty Resin & Chemical, will remain in an active role; Genesis Capital served as financial advisor to Polytek.
-
Medbio (Graham Partners) Acquires Polymer Conversions
September 1, 2020
Medical Devices
Graham Partners’ portfolio company Medbio, an outsourced medical device manufacturer based in Grand Rapids, Michigan, has acquired Polymer Conversions, Inc., a Western New York contract molder. The add‑on expands Medbio’s geographic footprint and injection‑molding and assembly capabilities, creating cross‑selling opportunities and expected operational synergies for the combined medical‑device manufacturing platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.